Vaqta Market Report 2026

Vaqta Market Overview

• The Vaqta market growth in the historic period has been driven by expansion of routine immunization schedules, rising incidence of hepatitis a outbreaks • Market expansion is supported by increasing focus on universal vaccination coverage, rising investments in public health infrastructure • Growth Driver: Rising Hepatitis A Cases Driving Demand for Preventive Vaccination Solutions • North America was the largest region in 2025.

What Is Covered Under Vaqta Market?

Vaqta is a vaccine that prevents hepatitis A, a viral infection that affects the liver. It is an inactivated (killed) virus vaccine, meaning it contains a virus that has been killed, which cannot cause the disease but stimulates the immune system to protect against future infections. Vaqta is a safe and effective vaccine that helps protect against hepatitis A, reducing the risk of liver disease caused by this viral infection. The main indications in the vaqta market are hepatitis A vaccination, travel vaccination, and routine vaccination. Hepatitis A vaccination refers to a preventive medical intervention that protects individuals against hepatitis A virus (HAV), a contagious virus that primarily affects the liver. The age groups are categorized into pediatrics, adults, and the elderly, while the distribution channels include hospitals and clinics, retail pharmacies, and specialty pharmacies. The end users comprise hospitals, clinics, ambulatory care facilities, and home care settings.

What Is The Vaqta Market Growth Forecast?

The growth in the forecast period can be attributed to increasing focus on universal vaccination coverage, rising investments in public health infrastructure, expansion of adult and elderly immunization programs, growing demand for combination vaccine strategies, increasing adoption in emerging economies. Major trends in the forecast period include increasing emphasis on preventive vaccination programs, rising adoption of travel-related immunization, growing focus on adult immunization coverage, expansion of cold-chain vaccine distribution, enhanced public health awareness campaigns.

Global Vaqta Market Segmentation

1) By Indication: Hepatitis A Vaccination, Travel Vaccination, Routine Vaccination 2) By Age Group: Pediatrics, Adults, Elderly 3) By Distribution Channel: Hospital And Clinics, Retail Pharmacies, Specialty Pharmacies 4) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Vaqta Market?

The rise in hepatitis A cases is expected to propel the growth of the vaqta market going forward. Hepatitis A is a highly contagious viral infection that affects the liver caused by the hepatitis A virus (HAV). The rise in hepatitis A cases can be attributed to several factors, including poor sanitation and hygiene, outbreaks in communities, unvaccinated populations, foodborne outbreaks, and environmental factors. The vaqta vaccine helps combat rising hepatitis A cases by preventing the spread of the virus, especially in high-risk areas. For instance, in April 2025, according to the Health Security Agency UK-based government agency In the UK, hepatitis A virus infections typically number around 400 cases per year, but cases have risen, exceeding 800 in 2024. Therefore, the rise in hepatitis A cases is driving the growth of the vaqta industry. The rise in the prevalence of chronic diseases is expected to propel the growth of the vaqta market going forward. Chronic diseases are long-lasting conditions that persist for a year or more and require ongoing medical attention or limit activities of daily living. These diseases generally progress slowly and can be managed but not cured. The prevalence of chronic diseases is due to aging populations, unhealthy lifestyles, and better detection and diagnosis. Vaqta plays a crucial preventive role in protecting individuals with chronic conditions from acquiring hepatitis A. For individuals with liver-related diseases or those with compromised immune systems, this vaccination can be critical in preventing further liver damage and managing overall health risks. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year, there are 41 million deaths worldwide, accounting for 74% of all fatalities attributed to chronic diseases. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the rise in the prevalence of chronic diseases is driving the growth of the vaqta industry. The growing healthcare expenditure is expected to propel the growth of the vaqta market going forward. Healthcare expenditure refers to the total amount of money spent on health services and products within a specific period, typically measured annually. The growing healthcare expenditure is driven by aging populations, rising chronic diseases, medical advancements, and increased healthcare access. The rising healthcare expenditure boosts access to Vaqta by funding vaccination programs and expanding preventive care initiatives. For instance, in May 2024, according to the Office for National Statistics (ONS), a UK-based government agency for national statistics, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, the growing healthcare expenditure is driving the growth of the vaqta industry.

Key Players In The Global Vaqta Market

Major companies operating in the vaqta market are Merck & Co. Inc.

Regional Insights

North America was the largest region in the vaqta market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vaqta Market?

The vaqta market consists of sales of hepatitis A vaccine, combination vaccines, and vaccine adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vaqta Market Report 2026?

The vaqta market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vaqta industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.